ABBV vs NONOF: Which Stock is Better?
Side-by-side comparison of AbbVie Inc and Novo Nordisk A/S in 2026
ABBV
AbbVie Inc
$257.65
NONOF
Novo Nordisk A/S
$45.25
Key Metrics Comparison
| Metric | ABBV | NONOF | Winner |
|---|---|---|---|
| Market Cap | $334.34B | $317.17B | ABBV |
| P/E Ratio | 166.70 | 18.73 | NONOF |
| EPS (TTM) | $1.32 | $N/A | ABBV |
| Revenue Growth | 9.1% | 0.0% | ABBV |
| Gross Margin | 70.2% | 0.0% | ABBV |
Analyze ABBV
Full quant analysis
Analyze NONOF
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABBV or NONOF a better investment?
Comparing ABBV and NONOF: AbbVie Inc has a market cap of $334.34B while Novo Nordisk A/S has $317.17B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABBV and NONOF?
ABBV (AbbVie Inc) and NONOF (Novo Nordisk A/S) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABBV or NONOF?
Based on P/E ratios, NONOF trades at a lower multiple (18.7x vs 166.7x).
Which is growing faster: ABBV or NONOF?
ABBV has higher revenue growth at 9.1% vs 0.0% for NONOF.
Which company is more profitable: ABBV or NONOF?
AbbVie Inc (ABBV) has higher gross margins at 70.2% compared to 0.0% for NONOF.
Which is the larger company: ABBV or NONOF?
AbbVie Inc (ABBV) is larger with a market cap of $334.34B compared to $317.17B for NONOF.
Should I buy ABBV or NONOF in 2026?
Both ABBV and NONOF have investment merit. ABBV trades at $257.65 while NONOF trades at $45.25. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABBV and NONOF stock?
Key differences: Market Cap ($334.34B vs $317.17B), P/E Ratio (166.7x vs 18.7x), Revenue Growth (9.1% vs 0.0%), Gross Margin (70.2% vs 0.0%).
Should I buy ABBV or NONOF in 2026?
The choice between ABBV and NONOF depends on your investment goals. ABBV shows higher revenue growth (9.1%). ABBV has better margins (70.2%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABBV and NONOF?
ABBV (AbbVie Inc) has a market cap of $334.34B, while NONOF (Novo Nordisk A/S) has a market cap of $317.17B. ABBV is the larger company by market value.